Cancer Immunotherapy and Medical Imaging Research Trends from 2003 to 2023: A Bibliometric Analysis
DOI: https://doi.org/10.2147/jmdh.s457367
2024-05-06
Journal of Multidisciplinary Healthcare
Abstract:Shuli Tang, 1, &ast Tiantian Fan, 2, &ast Xinxin Wang, 2 Can Yu, 2 Chunhui Zhang, 1 Yang Zhou 2 1 Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150010, People's Republic of China; 2 Department of Radiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150010, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yang Zhou, Department of Radiology, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, Heilongjiang, 150010, People's Republic of China, Tel +86-451-85718915, Email Purpose: With the rapid development of immunotherapy, cancer treatment has entered a new phase. Medical imaging, as a primary diagnostic method, is closely related to cancer immunotherapy. However, until now, there has been no systematic bibliometric analysis of the state of this field. Therefore, the main purpose of this article is to clarify the past research trajectory, summarize current research hotspots, reveal dynamic scientific developments, and explore future research directions. Patients and Methods: A comprehensive search was conducted on the Web of Science Core Collection (WoSCC) database to identify publications related to immunotherapy specifically for the medical imaging of carcinoma. The search spanned the period from the year 2003 to 2023. Several analytical tools were employed. These included CiteSpace (6.2.4), and the Microsoft Office Excel (2016). Results: By searching the database, a total of 704 English articles published between 2003 and 2023 were obtained. We have observed a rapid increase in the number of publications since 2018. The two most active countries are the United States (n=265) and China (n=170). Pittock, Sean J and Abu-sbeih, Hamzah are very concerned about the relationship between cancer immunotherapy and medical images and have published more academic papers (n = 5; n = 4). Among the top 10 co-cited authors, Topalian Sl (n=43) cited ranked first, followed by Graus F (n=40) cited. According to clustering, timeline, and burst word analysis, the results show that the current research focus is on "MRI", "deep learning", "tumor microenvironment" and so on. Conclusion: Medical imaging and cancer immunotherapy are hot topics. The United States is the country with the most publications and the greatest influence in this field, followed by China. "MRI", "PET/PET-CT", "deep learning", "immune-related adverse events" and "tumor microenvironment" are currently hot research topics and potential targets. Keywords: bibliometric analysis, cancer, immunotherapy, medical imaging, CiteSpace Cancer Cancer is the second leading cause of human mortality. Data from 2020 indicates that there were 180 million cancer patients, and it is projected that global cancer incidence will continue to rise from 2020 to 2040. By 2040, it is estimated that there will be approximately 280 million new cancer cases annually, representing a 55% increase compared to 2020. 1 In 2011, the United States FDA approved the first immune checkpoint inhibitor, Ipilimumab, for second-line treatment of advanced melanoma, marking the beginning of a new era in cancer immunotherapy. 2 Immunotherapy is altering the treatment paradigm for cancer, ushering in a new phase of development. However, while immunotherapy enhances the immune system's capacity to target tumor cells, it may also inadvertently damage other organs and tissues, increasing the risk of patients developing autoimmune diseases and causing side effects distinct from traditional cancer treatment methods. Moreover, unlike traditional cancer treatment modalities, patients undergoing immunotherapy may experience pseudo-progress ion or hyper-progression, 3 necessitating timely assessment and treatment modifications. Additionally, despite immunotherapy becoming a key component of cancer treatment, only 27.3% of individuals experience clinical benefits, 4 and 40% to 70% of the population develops acquired resistance. 5–7 Therefore, the need for supplementary tools to predict, assess, and monitor the efficacy and adverse reactions of immunotherapy is evident. Medical imaging is the visual representation process of the structure and function of various tissues and organs in the human body, used for clinical purposes and medical scientific exploration. 8 The relationship between tumor treatment effectiveness and medical imaging is closely intertwined. The continually evolving field of immunotherapy further highlights the critical issue of imaging assessment while also presenting new opportunities for the developm -Abstract Truncated-
health care sciences & services